524 related articles for article (PubMed ID: 18801417)
61. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
62. A novel rat medial prefrontal cortical slice preparation to investigate synaptic transmission from amygdala to layer V prelimbic pyramidal neurons.
Orozco-Cabal L; Pollandt S; Liu J; Vergara L; Shinnick-Gallagher P; Gallagher JP
J Neurosci Methods; 2006 Mar; 151(2):148-58. PubMed ID: 16154203
[TBL] [Abstract][Full Text] [Related]
63. Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterization.
Malherbe P; Knoflach F; Marcuz A; Bohnert C; Weber M; Knust H; Ratni H; Spooren W; Ballard TM; Bissantz C
Neuropharmacology; 2014 Nov; 86():259-72. PubMed ID: 25107588
[TBL] [Abstract][Full Text] [Related]
64. Orexin-A excites pyramidal neurons in layer 2/3 of the rat prefrontal cortex.
Yan J; He C; Xia JX; Zhang D; Hu ZA
Neurosci Lett; 2012 Jun; 520(1):92-7. PubMed ID: 22617634
[TBL] [Abstract][Full Text] [Related]
65. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
66. Synaptic efficacy during repetitive activation of excitatory inputs in primate dorsolateral prefrontal cortex.
González-Burgos G; Krimer LS; Urban NN; Barrionuevo G; Lewis DA
Cereb Cortex; 2004 May; 14(5):530-42. PubMed ID: 15054069
[TBL] [Abstract][Full Text] [Related]
67. Impaired developmental switch of short-term plasticity in pyramidal cells of dysplastic cortex.
Chen HX; Xiang H; Roper SN
Epilepsia; 2007 Jan; 48(1):141-8. PubMed ID: 17241221
[TBL] [Abstract][Full Text] [Related]
68. Inflammation and inflammatory agents activate protein kinase C epsilon translocation and excite guinea-pig submucosal neurons.
Poole DP; Matsuyama H; Nguyen TV; Eriksson EM; Fowler CJ; Furness JB
Gastroenterology; 2007 Oct; 133(4):1229-39. PubMed ID: 17765238
[TBL] [Abstract][Full Text] [Related]
69. Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitarii.
Sekizawa S; Joad JP; Bonham AC
J Physiol; 2003 Oct; 552(Pt 2):547-59. PubMed ID: 14561836
[TBL] [Abstract][Full Text] [Related]
70. PKC and polyamine modulation of GluR2-deficient AMPA receptors in immature neocortical pyramidal neurons of the rat.
Shin J; Shen F; Huguenard J
J Physiol; 2007 Jun; 581(Pt 2):679-91. PubMed ID: 17379631
[TBL] [Abstract][Full Text] [Related]
71. Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors.
Olijslagers JE; de Kloet ER; Elgersma Y; van Woerden GM; Joëls M; Karst H
Eur J Neurosci; 2008 May; 27(10):2542-50. PubMed ID: 18547242
[TBL] [Abstract][Full Text] [Related]
72. Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised.
Sanger GJ; Tuladhar BR; Brown J; Aziz E; Sivakumar D; Furness JB
Auton Autacoid Pharmacol; 2007 Apr; 27(2):105-11. PubMed ID: 17391280
[TBL] [Abstract][Full Text] [Related]
73. Tachykinin NK(1)receptor-mediated inhibitory responses in the guinea-pig small intestine.
Lecci A; De Giorgio R; Barthó L; Sternini C; Tramontana M; Corinaldesi R; Giuliani S; Maggi CA
Neuropeptides; 1999 Feb; 33(1):91-7. PubMed ID: 10657476
[TBL] [Abstract][Full Text] [Related]
74. The modulation of orexin A on HCN currents of pyramidal neurons in mouse prelimbic cortex.
Li B; Chen F; Ye J; Chen X; Yan J; Li Y; Xiong Y; Zhou Z; Xia J; Hu Z
Cereb Cortex; 2010 Jul; 20(7):1756-67. PubMed ID: 19915095
[TBL] [Abstract][Full Text] [Related]
75. AMPA receptors are modulated by tachykinins in rat cerebellum neurons.
Pieri M; Severini C; Amadoro G; Carunchio I; Barbato C; Ciotti MT; Zona C
J Neurophysiol; 2005 Oct; 94(4):2484-90. PubMed ID: 16160091
[TBL] [Abstract][Full Text] [Related]
76. Tachykinin regulation of cholinergic transmission in the limbic/prefrontal territory of the rat dorsal striatum: implication of new neurokinine 1-sensitive receptor binding site and interaction with enkephalin/mu opioid receptor transmission.
Pérez S; Tierney A; Deniau JM; Kemel ML
J Neurochem; 2007 Dec; 103(6):2153-63. PubMed ID: 17949415
[TBL] [Abstract][Full Text] [Related]
77. Differential expression of functionally identified and immunohistochemically identified NK(1) receptors on sympathetic neurons.
Jobling P; Messenger JP; Gibbins IL
J Neurophysiol; 2001 May; 85(5):1888-98. PubMed ID: 11353005
[TBL] [Abstract][Full Text] [Related]
78. Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
Ukai M; Shinkai N; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):97-101. PubMed ID: 8905797
[TBL] [Abstract][Full Text] [Related]
79. Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.
Malherbe P; Knoflach F; Hernandez MC; Hoffmann T; Schnider P; Porter RH; Wettstein JG; Ballard TM; Spooren W; Steward L
Br J Pharmacol; 2011 Feb; 162(4):929-46. PubMed ID: 21039418
[TBL] [Abstract][Full Text] [Related]
80. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
